Abstract | BACKGROUND: PROCEDURE: The present study integrated clinical data regarding the occurrence of HVOD, graft versus host disease (GVHD), BU pharmacokinetics and GSTA1, GSTP1, GSTM1, and GSTT1 genotypes of 18 children who received BU in their pre-HSCT conditioning regimen. The children were all treated for congenital hemoglobinopathies and were all of Arab Moslem descent. RESULTS: The data demonstrate an association between GSTA1 and GSTP1 genotypes and BU-maximal concentration (C(max)) (P = 0.01, P = 0.02, respectively), area under the concentration-time curve (AUC) (P = 0.02, P = 0.01, respectively) and oral BU clearance/kg body weight (P < 0.02, P = 0.08, respectively). GSTM1-null individuals demonstrated lower BU-AUC/Kg compared to GSTM1-positive individuals. In addition, an association between GVHD and GSTM1-null genotype was found. CONCLUSIONS: GSTA1, GSTP1, and GSTM1 genotyping prior to HSCT in children with congenital hemoglobinopathies may allow better prediction of oral BU kinetics and the need for BU dose adjustment, as well as prediction of transplant related toxicity such as GVHD, thereby improving clinical outcome.
|
Authors | Ronit Elhasid, Norberto Krivoy, Jacob M Rowe, Eli Sprecher, Lior Adler, Hela Elkin, Edna Efrati |
Journal | Pediatric blood & cancer
(Pediatr Blood Cancer)
Vol. 55
Issue 6
Pg. 1172-9
(Dec 01 2010)
ISSN: 1545-5017 [Electronic] United States |
PMID | 20672371
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antineoplastic Agents, Alkylating
- glutathione S-transferase T1
- GSTA1 protein, human
- GSTP1 protein, human
- Glutathione S-Transferase pi
- Glutathione Transferase
- glutathione S-transferase M1
- Busulfan
|
Topics |
- Administration, Oral
- Adolescent
- Antineoplastic Agents, Alkylating
(pharmacokinetics, therapeutic use)
- Busulfan
(pharmacokinetics, therapeutic use)
- Case-Control Studies
- Child
- Child, Preschool
- Female
- Genotype
- Glutathione S-Transferase pi
(genetics)
- Glutathione Transferase
(genetics)
- Graft vs Host Disease
(drug therapy, genetics, pathology)
- Hematopoietic Stem Cell Transplantation
- Hemoglobinopathies
(genetics, pathology, therapy)
- Humans
- Infant
- Male
- Polymorphism, Genetic
(genetics)
- Retrospective Studies
- Tissue Distribution
|
|
Join CureHunter, for free Research Interface BASIC access!
Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease.
Find out why thousands of doctors, pharma researchers and patient activists
around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!
|